Clincosm LogoSign in Get a demo

pharmacogenetics

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacogenetics Analysis of Fentanyl Administered in Newborns

Recruiting
  • Fentanyl
  • +2 more
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 6, 2023

    Pharmacogenetics, Depressive Disorder, Major, Medication Therapy Management Trial in Tuscaloosa (Pharmacogenomic Screening)

    Withdrawn
    • Pharmacogenetics
    • +2 more
    • Pharmacogenomic Screening
    • Tuscaloosa, Alabama
      Tuscaloosa VAMC
    Aug 8, 2022

    Polypharmacy, Pharmacogenetics, Pharmacogenomic Testing Trial (Pharmacogenomic testing of a panel of important pharmacogenes to

    Not yet recruiting
    • Polypharmacy
    • +3 more
    • Pharmacogenomic testing of a panel of important pharmacogenes to detect genetic variants and evaluate the association between genetically predicted and measured drug metabolism
    • +2 more
    • (no location specified)
    Jun 17, 2022

    Cardiovascular Drugs Adverse Reaction

    Recruiting
    • Pharmacogenetics
    • +2 more
    • Oral Anticoagulant, Direct-Acting
    • Zagreb, Croatia
      UHC Zagreb
    Mar 23, 2022

    Pharmacogenetics, Anesthesia Trial (Pharmacogenomic optimisation of anaesthetic medications)

    Not yet recruiting
    • Pharmacogenetics
    • Anesthesia
    • Pharmacogenomic optimisation of anaesthetic medications
    • (no location specified)
    Sep 28, 2021

    Susceptibility Genes for APAP Induced Drug Induced LIver Injury

    Recruiting
    • Acetaminophen
    • +3 more
    • genetic polymorphism
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jul 14, 2021

    Anticoagulant, Pharmacogenetics, Community Pharmacy Services Trial in Zaragoza (acenocoumarol, control)

    Completed
    • Anticoagulant
    • +4 more
    • acenocoumarol
    • control
    • Zaragoza, Spain
      Centro de Salud Arrabal
    May 3, 2021

    Pharmacogenetics, HIV, Drug Monitoring Trial in Buenos Aires (Pharmacogenomic index, Therapeutic drug monitoring)

    Completed
    • Pharmacogenetics
    • +2 more
    • Pharmacogenomic index
    • Therapeutic drug monitoring
    • Buenos Aires, Caba, Argentina
      Hospital Italiano de Buenos Aires - Infectious Diseases Section
    Jul 27, 2020

    Pharmacogenetics Trial in Portland (Naproxen tablet)

    Unknown status
    • Pharmacogenetics
    • Naproxen tablet
    • Portland, Oregon
      Oregon Health & Science University
    Jun 25, 2020

    Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor

    Unknown status
    • Solid Tumors
    • +4 more
    • detection of genotype
    • Beijing, Beijing, China
    • +5 more
    Aug 27, 2019

    Capecitabine-based Chemotherapy Toxicities in Chinese Solid

    Unknown status
    • Solid Tumor
    • +4 more
    • detection of genotype
    • Beijing, Beijing, China
    • +6 more
    Aug 27, 2019

    Clozapine Induced Weight Gain

    Unknown status
    • Weight Gain
    • +2 more
    • No study intervention - observational study
    • Merthyr Tydfil, Wales, United Kingdom
      Cwm Taf University Health Board
    Jun 21, 2019

    Hypertension, Pharmacogenetics Trial in Helsinki (Amlodipine, Bisoprolol, Hydrochlorothiazide)

    Completed
    • Hypertension
    • Pharmacogenetics
    • Helsinki, Finland
      Helsinki University Central Hospital
    Sep 8, 2017

    Pharmacogenetics, Medication Therapy Management Trial in Durham (MTM with PGx)

    Completed
    • Pharmacogenetics
    • Medication Therapy Management
    • MTM with PGx
    • Durham, North Carolina
      Duke Health Center at Southpoint
    Apr 17, 2015

    Methamphetamine, Amphetamine Dependence, Pharmacogenetics Trial in Los Angeles (Bupropion)

    Completed
    Has Results
    • Methamphetamine
    • +4 more
    • Los Angeles, California
      UCLA Clinical Research Site 910 Vine St
    Jan 10, 2014

    Attention Deficit Disorder With Hyperactivity, Methylphenidate, Pharmacogenetics Trial in Anyang (norepinephrine transporter

    Completed
    • Attention Deficit Disorder With Hyperactivity
    • +2 more
    • norepinephrine transporter polymorphism,
    • Anyang, Gyeonggi-do, Korea, Republic of
      Hallym University Sacred Heart Hospital
    Oct 4, 2011

    Pharmacogenetics, Healthy Trial in Barcelona (Risperidone, Placebo, Haloperidol)

    Unknown status
    • Pharmacogenetics
    • Healthy
    • Barcelona, Spain
    • +1 more
    Apr 15, 2011

    MDD, Antidepressive Agents, Pharmacogenetics Trial in Tainan (Venlafaxine, Fluoxetine)

    Unknown status
    • Major Depressive Disorder
    • +4 more
    • Tainan, Taiwan
      National Cheng-Kung University Hospital
    Sep 15, 2010

    Therapeutic Equivalency, Pharmacogenetics Trial in Gwangju (Rebamide)

    Completed
    • Therapeutic Equivalency
    • Pharmacogenetics
    • Gwangju, Korea, Republic of
      Institute of Bioeqivalence and Bridging Study, College of Pharma
    Oct 18, 2009